Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the market grown in recent years?

The market for thyroid eye disease (TED) has seen significant growth lately. Projections for its expansion indicate a rise from $2.15 billion in 2024, to $2.30 billion in 2025, showing a compound annual growth rate (CAGR) of 7.0%. The past growth in this market segment is due to an increase in thyroid disorders, a greater emphasis on patient-focused care, a rise in the demand for cosmetic procedures, a higher prevalence of TED, and more options available for its treatment.

How is the market size expected to evolve during the forecast period?

The market for Thyroid Eye Disease (TED) is projected to witness considerable expansion in the upcoming years. The market’s expected growth is poised to reach $2.97 billion by 2029, reflecting a Compound Annual Growth Rate (CAGR) of 6.6%. This surge during the forecast period can be ascribed to the growing incidences of Graves’ disease, increased industry-specific funding, a rise in healthcare expenditure, more widespread usage of thyroid hormone replacement therapy, and the escalating prevalence of thyroid disease. Key trends anticipated during this forecast period encompass technological advancements, increased research and development activities, introduction of innovative drugs, improvements in treatment methodologies, and emergence of new surgical techniques.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

What are the leading drivers of growth in the market?

The prevalence of thyroid disorders is anticipated to boost the advancement of the thyroid eye disease (TED) market. Thyroid disorders are medical conditions that disrupt the functioning of the thyroid gland, leading to a hormonal imbalance causing conditions like hypothyroidism, hyperthyroidism, goiter, and TED. The surge in thyroid disorders is attributed to factors such as increased iodine consumption, autoimmune diseases, heredity, and heightened awareness leading to better diagnosis rates. Thyroid Eye Disease (TED), a common and dangerous complication of Graves’ disease, contributes significantly to the increase in thyroid disorder cases, thereby intensifying the overall pressure and cognizance of thyroid-related ailments. For example, the Canadian Cancer Society, a community-based non-profit organization based in Canada, predicted in May 2024 that an approximate 6,600 new thyroid cancer cases are expected to emerge in Canada in 2024, with an estimated projection of around 280 deaths. Thus, the escalation in thyroid disorders is fuelling the expansion of the thyroid eye disease (TED) market.

What are the market segments in the industry?

The thyroid eye disease (TED) market covered in this report is segmented –

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Others Drug Type

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

Which leading companies are shaping the growth of the market?

Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

What are the key trends shaping the future of the market?

Prominent players in the thyroid eye disease (TED) market are concentrating on ground-breaking products such as monoclonal antibody therapies, aiming to create more targeted and efficient treatments to lessen inflammation, better proptosis, and improve patient results overall. These therapies involve utilising lab-created antibodies designed to replicate the immune system’s function of identifying and neutralising particular pathogens or abnormal cells. For example, Amgen Inc., a biotechnology firm based in the US, revealed in September 2024 that TEPEZZA (teprotumumab), specifically for treating active TED, received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW). This rare and potentially sight-threatening autoimmune disorder therapy is the first and only FDA-sanctioned, providing a specialised solution to alleviate inflammation, swelling, and other severe symptoms of the disease. This endorsement is especially crucial for Japanese patients, as it presents a new, effective approach to handle TED, a progressive and rare disorder causing eye protrusion, vision challenges, and eye discomfort.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300

Which geographic areas are influencing the growth of the market?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Digestive Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Digestive Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report

Digestive Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: